Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Nutr., 12 September 2025

Sec. Clinical Nutrition

Volume 12 - 2025 | https://doi.org/10.3389/fnut.2025.1676657

Correction: Partially hydrolyzed, whey-based infant formula with six human milk oligosaccharides, B. infantis LMG11588, and B. lactis CNCM I-3446 is safe, well tolerated, and improves gut health: a staged analysis of a randomized trial

This article is a correction to:

  1. Partially hydrolyzed, whey-based infant formula with six human milk oligosaccharides, B. infantis LMG11588, and B. lactis CNCM I-3446 is safe, well tolerated, and improves gut health: a staged analysis of a randomized trial

    1. Read original article
Jean-Charles Picaud, Jean-Charles Picaud1,2*Olivier ClarisOlivier Claris3Mercedes Gil-CamposMercedes Gil-Campos4Ignacio Salamanca De La CuevaIgnacio Salamanca De La Cueva5Luc CornetteLuc Cornette6Philippe AllietPhilippe Alliet7Andr LkAndré Léké8Mireille CastanetMireille Castanet9Hugues PiloquetHugues Piloquet10Virginie de HalleuxVirginie de Halleux11Delphine MitanchezDelphine Mitanchez12Yvan VandenplasYvan Vandenplas13Pierre MatonPierre Maton14Frank JochumFrank Jochum15Dirk OlbertzDirk Olbertz16Sergio Negre PolicarpoSergio Negre Policarpo17Luca LavalleLuca Lavalle18Cecilia FumeroCecilia Fumero18Paula Rodriguez-GarciaPaula Rodriguez-Garcia19Janne Marie MollJanne Marie Moll19Irma Silva-ZolezziIrma Silva-Zolezzi20Boutaina ZemraniBoutaina Zemrani20Nicholas P. HaysNicholas P. Hays20Norbert SprengerNorbert Sprenger21Javier Miranda-MalleaJavier Miranda-Mallea22
  • 1Department of Neonatology, Hôpital de La Croix-Rousse, Lyon, France
  • 2CarMen Laboratory, INSERM, INRA, Université Claude Bernard Lyon 1, Pierre-Bénite, Lyon, France
  • 3Department of Neonatology, Hôpital Femme Mère Enfants, Bron, France
  • 4Paediatric Metabolism Unit, Reina Sofia University Hospital, University of Córdoba, IMIBIC, CIBEROBN, Córdoba, Spain
  • 5Department of Pediatrics, Instituto Hispalense de Pediatria, Sevilla, Spain
  • 6Department of Neonatology, AZ Sint-Jan Hospital, Brugge, Belgium
  • 7Department of Pediatrics, Jessa Hospital, Hasselt, Belgium
  • 8Neonatal Medicine and Intensive Care, Centre Hospitalier Universitaire Amiens Picardie, Amiens, France
  • 9CIC INSERM U1404, Department of Pediatrics, Rouen University Hospital Charles Nicole, Rouen, France
  • 10Child Chronic Disease Service, Centre Hospitalier Universitaire de Nantes, Nantes, France
  • 11Neonatology Division, Centre Hospitalier Universitaire de Liège – Centre Hospitalier Universitaire de la Citadelle, Liège, Belgium
  • 12Service de Néonatologie, Centre Hospitalier Universitaire de Tours, Tours, France
  • 13KidZ Health Castle, Vrije Universiteit Brussel, UZ Brussel, Brussels, Belgium
  • 14Service Néonatal, Clinique CHC-Montlégia, Liège, Belgium
  • 15Department of Pediatrics, Evangelisches Waldkrankenhaus Spandau, Berlin, Germany
  • 16Department of Neonatology, Klinikum Südstadt Rostock, Rostock, Germany
  • 17Department of Pediatrics, Hospital Quironsalud, Valencia, Spain
  • 18Clinical Research Unit, Nestlé Research, Lausanne, Switzerland
  • 19Cmbio, Copenhagen, Denmark
  • 20Clinical and Nutritional Research Unit, Nestlé Product Technology Center – Nutrition, Vevey, Switzerland
  • 21Nestlé Institute of Health Sciences, Nestlé Research, Lausanne, Switzerland
  • 22Department of Pediatrics, Hospital Vithas, Valencia, Spain

A Correction on
Partially hydrolyzed, whey-based infant formula with six human milk oligosaccharides, B. infantis LMG11588, and B. lactis CNCM I-3446 is safe, well tolerated, and improves gut health: a staged analysis of a randomized trial

by Picaud, J.–C., Claris, O., Gil-Campos, M., De La Cueva, I. S., Cornette, L., Alliet, P., Léké, A., Castanet, M., Piloquet, H., de Halleux, V., Mitanchez, D., Vandenplas, Y., Maton, P., Jochum, F., Olbertz, D., Policarpo, S. N., Lavalle, L., Fumero, C., Rodriguez-Garcia, P., Moll, J. M., Silva-Zolezzi, I., Zemrani, B., Hays, N. P., Sprenger, N., and Miranda-Mallea, J. (2025). Front. Nutr. 12:1628847. doi: 10.3389/fnut.2025.1628847

In the published article, there was an error in the Supplementary materials. Supplementary Tables S2, S3, and S4 were omitted. In addition, Supplementary Figure S1, Supplementary Figure S2, and Supplementary Figure S3 were published without figure legends with the original version of this paper. To correct these errors, the files have been replaced with a consolidated file containing all the Supplementary Material in one document.

The original version of this article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: bifidobacteria, gastrointestinal tolerance, growth, gut health, microbiota

Citation: Picaud J-C, Claris O, Gil-Campos M, De La Cueva IS, Cornette L, Alliet P, Léké A, Castanet M, Piloquet H, de Halleux V, Mitanchez D, Vandenplas Y, Maton P, Jochum F, Olbertz D, Policarpo SN, Lavalle L, Fumero C, Rodriguez-Garcia P, Moll JM, Silva-Zolezzi I, Zemrani B, Hays NP, Sprenger N and Miranda-Mallea J (2025) Correction: Partially hydrolyzed, whey-based infant formula with six human milk oligosaccharides, B. infantis LMG11588, and B. lactis CNCM I-3446 is safe, well tolerated, and improves gut health: a staged analysis of a randomized trial. Front. Nutr. 12:1676657. doi: 10.3389/fnut.2025.1676657

Received: 30 July 2025; Accepted: 01 August 2025;
Published: 12 September 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Picaud, Claris, Gil-Campos, De La Cueva, Cornette, Alliet, Léké, Castanet, Piloquet, de Halleux, Mitanchez, Vandenplas, Maton, Jochum, Olbertz, Policarpo, Lavalle, Fumero, Rodriguez-Garcia, Moll, Silva-Zolezzi, Zemrani, Hays, Sprenger and Miranda-Mallea. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Jean-Charles Picaud, amVhbi1jaGFybGVzLnBpY2F1ZEBjaHUtbHlvbi5mcg==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.